US Stock MarketDetailed Quotes

Vertex Pharmaceuticals (VRTX)

Watchlist
  • 468.040
  • +0.690+0.15%
Trading Jan 23 09:43 ET
118.75BMarket Cap32.94P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vertex Pharmaceuticals (VRTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
10.99%3.08B
12.06%2.96B
2.96%2.77B
11.66%11.02B
15.66%2.91B
11.61%2.77B
6.11%2.65B
13.30%2.69B
10.51%9.87B
9.34%2.52B
Operating revenue
10.99%3.08B
11.28%2.94B
2.59%2.76B
11.66%11.02B
15.66%2.91B
11.61%2.77B
6.11%2.65B
13.30%2.69B
10.51%9.87B
9.34%2.52B
Cost of revenue
5.65%414.8M
9.57%407.5M
5.95%363M
21.26%1.53B
15.05%423.4M
23.19%392.6M
20.51%371.9M
28.36%342.6M
16.84%1.26B
29.90%368M
Gross profit
11.86%2.66B
12.47%2.56B
2.52%2.41B
10.25%9.49B
15.76%2.49B
9.91%2.38B
4.08%2.27B
11.39%2.35B
9.64%8.61B
6.45%2.15B
Operating expense
14.03%1.42B
4.80%1.4B
21.59%1.38B
101.45%9.72B
248.95%6B
16.19%1.25B
27.71%1.34B
15.06%1.13B
34.05%4.83B
59.78%1.72B
Selling and administrative expenses
19.71%445.1M
14.08%424.6M
15.67%396.4M
28.83%1.46B
2.30%377.6M
40.94%371.8M
41.74%372.2M
42.14%342.7M
20.31%1.14B
38.03%369.1M
Research and development costs
11.62%977.7M
1.22%978.4M
24.15%979.7M
123.81%8.26B
316.30%5.63B
8.14%875.9M
23.02%966.6M
6.26%789.1M
38.94%3.69B
66.96%1.35B
Operating profit
9.47%1.24B
23.46%1.15B
-15.22%1.03B
-106.17%-233.4M
-919.79%-3.52B
3.72%1.13B
-17.72%934.9M
8.18%1.22B
-11.05%3.78B
-54.49%428.9M
Net non-operating interest income expense
-1.84%122.4M
-19.03%118.7M
-30.97%117.9M
-0.54%567.5M
-25.75%125.4M
-20.57%124.7M
9.81%146.6M
53.60%170.8M
535.41%570.6M
127.02%168.9M
Non-operating interest income
-4.92%125.7M
-21.79%122.4M
-33.28%120.9M
-2.70%598.1M
-28.58%128.2M
-21.26%132.2M
8.15%156.5M
47.80%181.2M
325.10%614.7M
108.72%179.5M
Non-operating interest expense
-56.00%3.3M
-62.63%3.7M
-71.15%3M
-30.61%30.6M
-73.58%2.8M
-31.19%7.5M
-11.61%9.9M
-8.77%10.4M
-19.53%44.1M
-8.62%10.6M
Other net income (expense)
-93.79%-62.4M
100.23%10.1M
-287.95%-418.6M
-397.22%-85.6M
723.43%4.53B
53.20%-32.2M
-4,029.92%-4.47B
68.62%-107.9M
126.84%28.8M
816.33%549.8M
Special income (charges)
-243.79%-52.6M
99.93%-3.1M
-422.82%-401M
-99.03%500K
711.67%4.54B
71.08%-15.3M
-3,948.77%-4.45B
77.78%-76.7M
-10.26%51.6M
514.27%559.6M
-Less：Restructuring and merger&acquisition
-733.33%-1.9M
80.00%900K
2,300.00%2.2M
99.03%-500K
97.61%-1.2M
-75.00%300K
183.33%500K
94.74%-100K
10.26%-51.6M
-2,894.44%-50.3M
-Less:Impairment of capital assets
--0
--0
--379M
----
----
--0
--0
--0
----
----
-Less:Other special charges
263.33%54.5M
-99.95%2.2M
-74.22%19.8M
778.09%4.63B
391.57%87.5M
-70.99%15M
3,926.33%4.45B
-77.87%76.8M
356.36%527.1M
-21.24%17.8M
Other non- operating income (expenses)
42.01%-9.8M
157.14%13.2M
43.59%-17.6M
-277.63%-86.1M
-52.04%-14.9M
-6.29%-16.9M
-1,543.75%-23.1M
-2,500.00%-31.2M
86.17%-22.8M
68.49%-9.8M
Income before tax
6.10%1.3B
137.83%1.28B
-42.90%730.4M
-94.33%248.5M
-0.97%1.14B
3.81%1.22B
-391.97%-3.39B
43.48%1.28B
3.48%4.38B
6.58%1.15B
Income tax
20.82%215.9M
23.57%250.1M
-53.15%84.1M
3.14%784.1M
25.00%223.5M
24.18%178.7M
-17.66%202.4M
-6.36%179.5M
-16.50%760.2M
-30.67%178.8M
Net income
3.59%1.08B
128.74%1.03B
-41.22%646.3M
-114.80%-535.6M
-5.76%913M
0.98%1.05B
-492.44%-3.59B
57.13%1.1B
8.96%3.62B
18.31%968.8M
Net income continuous Operations
3.59%1.08B
128.74%1.03B
-41.22%646.3M
-114.80%-535.6M
-5.76%913M
0.98%1.05B
-492.44%-3.59B
57.13%1.1B
8.96%3.62B
18.31%968.8M
Minority interest income
Net income attributable to the parent company
3.59%1.08B
128.74%1.03B
-41.22%646.3M
-114.80%-535.6M
-5.76%913M
0.98%1.05B
-492.44%-3.59B
57.13%1.1B
8.96%3.62B
18.31%968.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
3.59%1.08B
128.74%1.03B
-41.22%646.3M
-114.80%-535.6M
-5.76%913M
0.98%1.05B
-492.44%-3.59B
57.13%1.1B
8.96%3.62B
18.31%968.8M
Basic earnings per share
4.69%4.24
128.88%4.02
-40.85%2.52
-114.80%-2.08
-5.59%3.55
1.00%4.05
-492.11%-13.92
56.62%4.26
8.33%14.05
17.87%3.76
Diluted earnings per share
4.74%4.2
128.66%3.99
-40.86%2.49
-114.97%-2.08
-5.66%3.5
1.01%4.01
-495.45%-13.92
56.51%4.21
8.35%13.89
17.78%3.71
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 10.99%3.08B12.06%2.96B2.96%2.77B11.66%11.02B15.66%2.91B11.61%2.77B6.11%2.65B13.30%2.69B10.51%9.87B9.34%2.52B
Operating revenue 10.99%3.08B11.28%2.94B2.59%2.76B11.66%11.02B15.66%2.91B11.61%2.77B6.11%2.65B13.30%2.69B10.51%9.87B9.34%2.52B
Cost of revenue 5.65%414.8M9.57%407.5M5.95%363M21.26%1.53B15.05%423.4M23.19%392.6M20.51%371.9M28.36%342.6M16.84%1.26B29.90%368M
Gross profit 11.86%2.66B12.47%2.56B2.52%2.41B10.25%9.49B15.76%2.49B9.91%2.38B4.08%2.27B11.39%2.35B9.64%8.61B6.45%2.15B
Operating expense 14.03%1.42B4.80%1.4B21.59%1.38B101.45%9.72B248.95%6B16.19%1.25B27.71%1.34B15.06%1.13B34.05%4.83B59.78%1.72B
Selling and administrative expenses 19.71%445.1M14.08%424.6M15.67%396.4M28.83%1.46B2.30%377.6M40.94%371.8M41.74%372.2M42.14%342.7M20.31%1.14B38.03%369.1M
Research and development costs 11.62%977.7M1.22%978.4M24.15%979.7M123.81%8.26B316.30%5.63B8.14%875.9M23.02%966.6M6.26%789.1M38.94%3.69B66.96%1.35B
Operating profit 9.47%1.24B23.46%1.15B-15.22%1.03B-106.17%-233.4M-919.79%-3.52B3.72%1.13B-17.72%934.9M8.18%1.22B-11.05%3.78B-54.49%428.9M
Net non-operating interest income expense -1.84%122.4M-19.03%118.7M-30.97%117.9M-0.54%567.5M-25.75%125.4M-20.57%124.7M9.81%146.6M53.60%170.8M535.41%570.6M127.02%168.9M
Non-operating interest income -4.92%125.7M-21.79%122.4M-33.28%120.9M-2.70%598.1M-28.58%128.2M-21.26%132.2M8.15%156.5M47.80%181.2M325.10%614.7M108.72%179.5M
Non-operating interest expense -56.00%3.3M-62.63%3.7M-71.15%3M-30.61%30.6M-73.58%2.8M-31.19%7.5M-11.61%9.9M-8.77%10.4M-19.53%44.1M-8.62%10.6M
Other net income (expense) -93.79%-62.4M100.23%10.1M-287.95%-418.6M-397.22%-85.6M723.43%4.53B53.20%-32.2M-4,029.92%-4.47B68.62%-107.9M126.84%28.8M816.33%549.8M
Special income (charges) -243.79%-52.6M99.93%-3.1M-422.82%-401M-99.03%500K711.67%4.54B71.08%-15.3M-3,948.77%-4.45B77.78%-76.7M-10.26%51.6M514.27%559.6M
-Less：Restructuring and merger&acquisition -733.33%-1.9M80.00%900K2,300.00%2.2M99.03%-500K97.61%-1.2M-75.00%300K183.33%500K94.74%-100K10.26%-51.6M-2,894.44%-50.3M
-Less:Impairment of capital assets --0--0--379M----------0--0--0--------
-Less:Other special charges 263.33%54.5M-99.95%2.2M-74.22%19.8M778.09%4.63B391.57%87.5M-70.99%15M3,926.33%4.45B-77.87%76.8M356.36%527.1M-21.24%17.8M
Other non- operating income (expenses) 42.01%-9.8M157.14%13.2M43.59%-17.6M-277.63%-86.1M-52.04%-14.9M-6.29%-16.9M-1,543.75%-23.1M-2,500.00%-31.2M86.17%-22.8M68.49%-9.8M
Income before tax 6.10%1.3B137.83%1.28B-42.90%730.4M-94.33%248.5M-0.97%1.14B3.81%1.22B-391.97%-3.39B43.48%1.28B3.48%4.38B6.58%1.15B
Income tax 20.82%215.9M23.57%250.1M-53.15%84.1M3.14%784.1M25.00%223.5M24.18%178.7M-17.66%202.4M-6.36%179.5M-16.50%760.2M-30.67%178.8M
Net income 3.59%1.08B128.74%1.03B-41.22%646.3M-114.80%-535.6M-5.76%913M0.98%1.05B-492.44%-3.59B57.13%1.1B8.96%3.62B18.31%968.8M
Net income continuous Operations 3.59%1.08B128.74%1.03B-41.22%646.3M-114.80%-535.6M-5.76%913M0.98%1.05B-492.44%-3.59B57.13%1.1B8.96%3.62B18.31%968.8M
Minority interest income
Net income attributable to the parent company 3.59%1.08B128.74%1.03B-41.22%646.3M-114.80%-535.6M-5.76%913M0.98%1.05B-492.44%-3.59B57.13%1.1B8.96%3.62B18.31%968.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 3.59%1.08B128.74%1.03B-41.22%646.3M-114.80%-535.6M-5.76%913M0.98%1.05B-492.44%-3.59B57.13%1.1B8.96%3.62B18.31%968.8M
Basic earnings per share 4.69%4.24128.88%4.02-40.85%2.52-114.80%-2.08-5.59%3.551.00%4.05-492.11%-13.9256.62%4.268.33%14.0517.87%3.76
Diluted earnings per share 4.74%4.2128.66%3.99-40.86%2.49-114.97%-2.08-5.66%3.51.01%4.01-495.45%-13.9256.51%4.218.35%13.8917.78%3.71
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.29%
Sample Name
Sample Code
 +1.71%
Sample Name
Sample Code
 +1.68%
4
Block
XYZ
+1.61%
5
Vistra Energy
VST
+1.12%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.73%
Sample Name
Sample Code
 +8.15%
Sample Name
Sample Code
 +4.18%
4
KE Holdings
BEKE
+3.90%
5
Pony AI
PONY
+3.84%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -